Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

High RiskFDA Drug
Medications & Supplements/Prescription Drugs

Edge Pharma Recalls Various Medications for Sterility and Manufacturing Issues

Agency Publication Date: January 24, 2022
Share:
Sign in to monitor this recall

Summary

Edge Pharma, LLC is recalling 113,123 units of various sterile and non-sterile medications because they may lack assurance of sterility or have deviations from manufacturing standards. The recall includes a wide range of products such as ALUM Concentrate, Lidocaine, Vancomycin, and various dental and topical gels. These products were distributed nationwide to hospitals, clinics, and physician offices. No injuries or incidents have been reported to date.

Risk

Using products that are supposed to be sterile but are contaminated can lead to serious, life-threatening infections, especially when the drugs are injected or used in the eyes. Manufacturing defects in non-sterile medications also pose a risk of infection or unexpected side effects.

What You Should Do

  1. This recall affects various sterile and non-sterile medications manufactured by Edge Pharma, LLC, including IV bags, pre-filled syringes, droppers, jars, and bottles.
  2. Check your clinical inventory for products with the Edge Pharma, LLC label. Affected products include various medications such as Lidocaine, Vancomycin, Mitomycin-C, and multiple dental gels. See the Affected Products section below for the full list of affected codes.
  3. Stop using the recalled products immediately.
  4. Contact Edge Pharma, LLC or your distributor to arrange for the return of any remaining stock. If you have any medical questions regarding used products, contact a healthcare provider.
  5. Healthcare providers who have administered these products should monitor patients for signs of infection or adverse reactions.
  6. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled product. Contact the manufacturer or your distributor to arrange return.

Affected Products

Product: ALUM Concentrate (Aluminum Potassium Sulfate Dodecahydrate in Sterile Water (PF) 30 g/300 ml, IV bag)
Variants: IV bag, Rx Only
Lot Numbers:
08-2021-25@2 (12/08/2021)
09-2021-08@1 (12/23/2021)
10-2021-20@3 (02/01/2022)
NDC:
05446-0637-03

Quantity: 30 bags

Product: Lidocaine HCl Sterile Buffered Solution for Injection (PF) 1%, 10mL per syringe
Variants: Single Use Syringe, For Infiltration and Nerve Block
Lot Numbers:
08-2021-27@3 (12/09/2021)
09-2021-24@1 (01/06/2022)
10-2021-14@2 (01/31/2022)
NDC:
05446-0850-10

Quantity: 4465 syringes

Product: Lidocaine HCl/Epinephrine, Sterile Buffered Solution for Injection (PF) 1% / 1:100,000, 3 mL per syringe
Variants: Single Use Syringe
Lot Numbers:
10-2021-25@4 (12/08/2021)
11-2021-08@6 (12/22/2021)
NDC:
05446-1268-01

Quantity: 8140 syringes

Product: Ceftazidime, Sterile Ophthalmic Solution for Injection, Preservative Free (11.25 mg/0.5 mL (22.5 mg/mL), 0.5mL syringe)
Variants: Single Use Syringe, For Intraocular Injection
Lot Numbers:
09-2021-01@6 (12/14/2021)
10-2021-27@4 (01/01/2022)
NDC:
05446-0733-01

Quantity: 168 syringes

Product: Cefuroxime, Sterile Ophthalmic Solution for Injection, Preservative Free, 3mg/0.3mL (10 mg/mL), 0.3 mL syringe
Variants: Single Use Syringe, For Intraocular Injection
Lot Numbers:
08-2021-30@1 (12/20/2021)
09-2021-21@5 (01/03/2022)
10-2021-18@5 (02/07/2022)
NDC:
05446-1003-01

Quantity: 1720 syringes

Product: Dexamethasone sodium phosphate, sterile otic solution for injection Preservative free, 19.2 mg/0.8mL (24mg/mL), 0.8 mL syringe
Variants: Single Use Syringe, For Otic Injection
Lot Numbers:
09-2021-28@1 (01/10/2022)
NDC:
05446-0848-01

Quantity: 323 syringes

Product: Edetate Disodium (EDTA), Sterile Ophthalmic Solution (PF) 1.5%, 10 mL per dropper
Variants: Single Dose Droptainer, Topical Ophthalmic Use
Lot Numbers:
10-2021-20@1 (02/10/2022)
NDC:
05446-1427-10

Quantity: 80 droppers

Product: Edetate Disodium (EDTA), Sterile Ophthalmic Solution, (PF) 3%, 10mL per dropper
Variants: Single Dose Droptainer, Topical Ophthalmic Use
Lot Numbers:
09-2021-22@1 (01/04/2022)
NDC:
05446-1428-10
Product: Epinephrine/Lidocaine HCl Sterile Ophthalmic Solution for Injection, Preservative Free, 0.025%/0.75%, 0.8 mL syringe
Variants: Single Use Syringe, For Intraocular Injection
Lot Numbers:
10-2021-18@4 (12/08/2021)
11-2021-01@3 (12/22/2021)
NDC:
05446-0863-01

Quantity: 2568 syringes

Product: Gemcitabine, Sterile Intravesical Solution, Preservative Free, 1g/50mL (20 mg/mL), 50 mL syringe
Variants: Single Dose Syringe, For Intravesical Use
Lot Numbers:
08-2021-18@1 (12/14/2021)
08-2021-27@1 (12/09/2021)
09-2021-01@4 (12/14/2021)
09-2021-08@2 (12/21/2021)
09-2021-14@6 (01/05/2021)
09-2021-16@4 (12/29/2021)
09-2021-17@4 (12/30/2021)
09-2021-22@3 (01/04/2022)
10-2021-27@3 (02/08/2022)
NDC:
05446-1566-50

Quantity: 627 syringes

Product: Lidocaine HCL / Bupivacaine HCL (contains Hyaluronidase 15 units/mL), Sterile Ophthalmic Solution (PF), 2%/0.375%, 8 mL syringe
Variants: Single Use Syringe
Lot Numbers:
10-2021-26@3 (12/04/2021)
11-2021-09@1 (12/23/2021)
NDC:
05446-1548-18

Quantity: 1202 syringes

Product: Vancomycin HCl, Sterile Ophthalmic Solution for Injection, Preservative Free, 8 mg/0.8mL (10 mg/mL), 0.8 mL syringe
Variants: Single Use Syringe, For Intraocular Injection
Lot Numbers:
08-2021-31@2 (12/12/2021)
09-2021-20@4 (01/02/2022)
NDC:
05446-0736-01

Quantity: 3360 syringes

Product: Vancomycin HCl in 0.9 % Sodium Chloride Injection, USP, 1,250 mg/250 mL, Single Use Bag (Preservative Free), 250 mL
Variants: IV Injection
Lot Numbers:
09-2021-13@3 (12/27/2021)
09-2021-30@5 (01/13/2022)
NDC:
05446-1456-01

Quantity: 1795 bags

Product: Vancomycin HCl in 0.9% Sodium Chloride Injection, USP, 1,500 mg/500 mL, Single Use Bag (Preservative Free), 500 mL
Variants: IV Injection
Lot Numbers:
08-2021-26@4 (12/08/2021)
09-2021-21@3 (01/04/2022)
NDC:
05446-1458-01

Quantity: 1825 bags

Product: Vancomycin HCl in 0.9% Sodium Chloride Injection, USP, 1,750mg/500mL, Single Use Bag (Preservative Free), 500 mL
Variants: IV Injection
Lot Numbers:
09-2021-09@6 (12/23/2021)
10-2021-13@5 (01/27/2022)
NDC:
05446-1459-01

Quantity: 749 bags

Product: Profound-PE Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl/Phenylephrine, 10% / 10% / 4% / 2%, Spear-Peppermint, 30g jar
Variants: Multiple Dose Container, Topical Oral Use
Lot Numbers:
07-2021-13@7 (01/09/2022)
07-2021-27@8 (01/23/2022)
08-2021-10@5 (02/01/2022)
NDC:
05446-0408-10

Quantity: 175 jars

Product: Phenol, Topical Solution (PF) Multiple Dose Vial, 89%, 3 mL
Variants: Topical Solution
Lot Numbers:
07-2021-12@9 (01/08/2022)
08-2021-11@10 (02/07/2022)
08-2021-12@12 (02/08/2022)
09-2021-22@5 (03/21/2022)
10-2021-07@8 (04/05/2022)
10-2021-08@4 (04/06/2022)
11-2021-01@7 (04/30/2022)
NDC:
05446-1211-03

Quantity: 1861 jars

Product: Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL bottle
Variants: Multiple Dose Container, Nasal Solution
Lot Numbers:
07-2021-02@7 (12/29/2021)
07-2021-23@4 (01/19/2022)
08-2021-11@7 (02/07/2022)
08-2021-23@8 (02/19/2022)
09-2021-24@10 (03/23/2022)
NDC:
05446-1045-03

Quantity: 231 bottles

Product: Vitamin K (Vitamin K ) Oral Solution (PF), 5 mg/mL, 1mL syringe
Variants: Single Dose Syringe, Oral Use
Lot Numbers:
10-2021-11@6 (01/09/2022)
11-2021-01@8 (01/30/2022)
NDC:
05446-1132-03

Quantity: 757 syringes

Product: Promethazine HCl Topical Ointment, 2.5% (25 mg/mL), 1.2 mL syringe
Variants: Single Dose Syringe, Topical Use Only
Lot Numbers:
08-2021-02@9 (12/15/2021)
08-2021-16@10 (12/29/2021)
09-2021-08@6 (01/21/2022)
09-2021-20@6 (02/02/2022)
10-2021-18@6 (03/02/2022)
NDC:
05446-1341-01

Quantity: 7788 syringes

Product: Tetracaine HCl Nasal Solution, 4%, 240 mL bottle
Variants: Multiple Dose Container, Intranasal Use
Lot Numbers:
06-2021-08@5 (12/05/2021)
07-2021-07@7 (01/03/2022)
07-2021-27@10 (01/23/2022)
10-2021-06@12 (04/04/2022)
NDC:
05446-1195-03

Quantity: 114 bottles

Product: Vancomycin HCl Oral Solution (PF) 125mg / 2.5mL (50 mg/mL), 2.5 mL syringe
Variants: Single Dose Syringe, Oral Use Only
Lot Numbers:
09-2021-10@3 (12/09/2021)
09-2021-17@6 (12/16/2021)
09-2021-24@8 (12/23/2021)
09-2021-30@7 (12/29/2021)
10-2021-13@6 (01/11/2022)
NDC:
05446-1348-01

Quantity: 6925 syringes

Product: Trypan Blue 0.03%, 0.5mL syringe, Sterile Ophthalmic Solution
Variants: Preservative Free, Single Use Syringe, For Intraocular Injection
Lot Numbers:
09-2021-10@3 (12/09/2021)
09-2021-17@6 (12/16/2021)
09-2021-24@8 (12/23/2021)
09-2021-30@7 (12/29/2021)
10-2021-13@6 (01/11/2022)
NDC:
05446-1348-01
Product: Methacholine Challenge 5-Syringe Test Kit, Sterile Inhalation Solution, PF
Variants: 3 mL per syringe, Test Kit
Lot Numbers:
09-2021-03@6 (12/16/2021)
10-2021-06@7 (01/18/2022)
NDC:
05446-1600-05

Quantity: 1007 syringes

Product: Methotrexate, USP, Sterile Solution for Injection (PF), 125 mg/5mL (2mg/mL), 5 mL syringe
Variants: Single Use Syringe
Lot Numbers:
09-2021-10@2 (12/23/2021)
10-2021-21@2 (02/01/2022)
11-2021-09@5 (02/21/2022)
NDC:
05446-1505-05

Quantity: 457 syringes

Product: Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL syringe
Variants: Single Dose Syringe, For Intravesical Use
Lot Numbers:
08-2021-24@5 (12/09/2021)
08-2021-27@2 (12/21/2021)
08-2021-31@5 (12/14/2021)
09-2021-02@2 (12/15/2021)
09-2021-09@2 (12/22/2021)
09-2021-15@3 (12/29/2021)
09-2021-22@2 (01/04/2022)
10-2021-26@5 (02/07/2022)
NDC:
05446-1416-01

Quantity: 860 syringes

Product: Mitomycin-C Sterile Ophthalmic Solution, Preservative Free, 0.32mg/0.8 mL (0.4mg/mL) 0.8 mL syringe
Variants: Single Use Syringe, Topical Ophthalmic Use
Lot Numbers:
11-2021-08@8 (12/18/2021)
NDC:
05446-1009-01

Quantity: 163 syringes

Product: Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL syringe
Variants: Single Use Syringe, Topical Ophthalmic Use
Lot Numbers:
11-2021-08@9 (12/18/2021)
NDC:
05446-1011-01

Quantity: 154 syringes

Product: Moxifloxacin, Sterile Ophthalmic Solution for Injection, Preservative Free, 0.8mg/0.8 mL (1mg/mL), 0.8 mL syringe
Variants: Single Use Syringe, For Intraocular Injection
Lot Numbers:
08-2021-26@2 (12/09/2021)
09-2021-23@1 (01/05/2022)
NDC:
05446-1050-01

Quantity: 860 syringes

Product: Neostigmine methylsulfate, 5 mg/5mL (1 mg/mL), 5 mL syringe
Variants: Single Use Syringe, For IV or IM Injection
Lot Numbers:
10-2021-07@1 (01/19/2022)
NDC:
05446-1549-05

Quantity: 160 syringes

Product: MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.13mL, 0.13 mL syringe
Variants: Single Use Syringe, For Intraocular Injection
Lot Numbers:
11-2021-01@2 (12/15/2021)
NDC:
05446-1661-13

Quantity: 199 syringes

Product: Phenol, Sterile Solution for Injection (PF), 6%, 5 mL vial
Variants: Single Use Vial, For Perineural Injection
Lot Numbers:
09-2021-14@5 (12/29/2021)
11-2021-04@2 (02/15/2022)
NDC:
05446-1476-05

Quantity: 309 vials

Product: Phenylephrine HCl / Tropicamide / Ciprofloxcin / Ketorolac Sterile Ophthalmic Solution, 10%/1%/0.3%/0.125%, 0.8 mL syringe
Variants: Single Use Syringe, Topical Ophthalmic Use
Lot Numbers:
08-2021-31@8 (12/21/2021)
10-2021-13@1 (01/19/2022)
NDC:
05446-1270-01

Quantity: 2463 vials

Product: Phenylephrine HCl 0.5 mg/5mL, (0.1 mg/mL), 5 mL syringe
Variants: Single Use Syringe, For IV Injection
Lot Numbers:
09-2021-09@4 (12/22/2021)
10-2021-14@1 (01/26/2022)
NDC:
05446-1545-05

Quantity: 3747 syringes

Product: Phenylephrine HCl, 1mg/10mL (0.1mg/mL), 10 mL syringe
Variants: Single Use Syringe, For IV Injection
Lot Numbers:
08-2021-26@3 (12/16/2021)
09-2021-16@5 (12/29/2021)
10-2021-07@2 (01/19/2022)
10-2021-22@1 (02/03/2022)
NDC:
05446-1544-10

Quantity: 6535 vials

Product: Phenylephrine HCl, Sterile Solution for Injection, (PF), 800 mcg/10mL (80 mcg/mL), syringe
Variants: Single Use Syringe, For IV Injection
Lot Numbers:
08-2021-27@4 (12/09/2021)
09-2021-17@1 (12/30/2021)
10-2021-15@1 (01/27/2022)
10-2021-28@1 (02/09/2022)
NDC:
05446-1652-01

Quantity: 5335 syringes

Product: PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250mL, (0.08 mg/mL), 250mL bag
Variants: Single use bag, For IV injection (PF)
Lot Numbers:
08-2021-24@6 (12/06/2021)
08-2021-31@7 (12/12/2021)
09-2021-07@3 (12/21/2021)
10-2021-20@2 (02/02/2022)
10-2021-28@2 (02/10/2022)
NDC:
05446-1667-01

Quantity: 3930 bags

Product: Phenylephrine HCl/Lidocaine, Sterile Ophthalmic Solution for Injection, Preservative Free, 1.5%/1%, 0.8mL syringe
Variants: Single Use Syringe, For Intraocular Injection
Lot Numbers:
09-2021-16@1 (12/29/2021)
NDC:
05446-1118-01

Quantity: 2750 syringes

Product: Phenylephrine HCl/Tropicamide, Sterile Ophthalmic Solution, 2.5%/1%, 15 mL dropper
Variants: Multiple Dose Droptainer, Topical Ophthalmic Use
Lot Numbers:
09-2021-15@1 (12/28/2021)
NDC:
05446-0815-01

Quantity: 363 droptainers

Product: Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac Sterile Ophthalmic Solution, 2.5%/0.25%/0.25%/0.125%, 0.5 mL syringe
Variants: Single Use Syringe, Topical Ophthalmic Use
Lot Numbers:
09-2021-15@2 (12/28/2021)
11-2021-02@3 (02/14/2022)
NDC:
05446-0993-01

Quantity: 2562 syringes

Product: Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/ Ketorolac Sterile Ophthalmic Solution, 10%/ 0.25%/ 0.25%/0.125%, 10 mL dropper
Variants: Multiple Dose Droptainer, Topical Ophthalmic Use
Lot Numbers:
11-2021-02@2 (12/16/2021)
NDC:
05446-0859-03

Quantity: 40 droptainers

Product: Betadine (povidone-iodine), Sterile Ophthalmic Solution, Preservative Free, 5% 0.5mL syringe
Variants: Single Use Syringe, Topical Ophthalmic Use
Lot Numbers:
10-2021-25@5 (12/09/2021)
NDC:
05446-1680-01

Quantity: 1773 syringes

Product: BLT Topical Cream, Benzocaine/Lidocaine/Tetracaine, 20%/8%/4%, 60gm jar
Variants: Multiple Dose Container, Topical Use
Lot Numbers:
06-2021-10@11 (12/07/2021)
06-2021-10@9 (12/07/2021)
06-2021-17@6 (12/14/2021)
06-2021-17@7 (12/14/2021)
06-2021-24@5 (12/21/2021)
06-2021-24@8 (12/21/2021)
07-2021-01@6 (12/28/2021)
07-2021-01@7 (12/28/2021)
07-2021-09@5 (01/01/2022)
07-2021-09@6 (01/05/2022)
07-2021-15@5 (01/01/2022)
07-2021-15@6 (01/01/2022)
07-2021-22@16 (01/19/2022)
07-2021-22@8 (01/01/2022)
07-2021-29@12 (01/25/2022)
07-2021-29@24 (01/25/2022)
08-2021-05@7 (02/01/2022)
08-2021-05@8 (02/01/2022)
08-2021-19@7 (02/15/2022)
08-2021-19@8 (02/15/2022)
08-2021-26@5 (02/22/2022)
09-2021-01@10 (02/28/2022)
09-2021-03@7 (03/02/2022)
09-2021-09@7 (03/08/2022)
09-2021-16@7 (03/15/2022)
09-2021-17@7 (03/16/2022)
09-2021-22@8 (03/21/2021)
09-2021-23@2 (03/22/2022)
09-2021-23@3 (03/22/2022)
09-2021-30@10 (03/29/2022)
09-2021-30@8 (03/29/2022)
10-2021-07@10 (04/05/2022)
10-2021-07@7 (04/05/2022)
10-2021-08@1 (04/06/2022)
10-2021-14@4 (04/12/2022)
10-2021-14@5 (04/12/2022)
10-2021-21@7 (04/19/2022)
10-2021-28@3 (04/26/2022)
NDC:
05446-1235-01

Quantity: 1173 jars

Product: Cantharidin Gel-Forming Suspension, 0.7%, 10 mL vial
Variants: Multiple Dose Vial, Topical Use
Lot Numbers:
06-2021-11@6 (12/08/2021)
07-2021-08@13 (01/04/2022)
08-2021-06@6 (02/02/2022)
08-2021-20@10 (02/16/2022)
08-2021-26@6 (02/22/2022)
08-2021-27@7 (02/23/2022)
09-2021-02@5 (03/01/2022)
09-2021-17@8 (03/16/2022)
09-2021-29@12 (03/28/2022)
NDC:
05446-0572-03

Quantity: 1173 vials

Product: Cantharidin PLUS, Cantharidin/Salicylic Acid Gel-Forming Suspension, 10 mL vial
Variants: Multiple Dose Vials, Topical Use
Lot Numbers:
06-2021-09@9 (12/06/2021)
06-2021-16@11 (12/13/2021)
06-2021-23@7 (12/20/2021)
06-2021-30@11 (12/27/2021)
07-2021-07@9 (01/03/2022)
07-2021-13@6 (01/09/2021)
07-2021-14@5 (01/10/2022)
07-2021-21@8 (01/17/2022)
07-2021-26@10 (01/22/2022)
08-2021-04@5 (01/31/2022)
08-2021-09@11 (02/05/2022)
08-2021-10@6 (02/06/2022)
08-2021-17@5 (02/13/2022)
08-2021-25@4 (02/21/2022)
09-2021-01@8 (02/28/2022)
09-2021-08@8 (03/07/2022)
09-2021-15@6 (03/14/2022)
09-2021-21@8 (03/20/2022)
09-2021-27@10 (03/26/2022)
10-2021-06@8 (04/04/2022)
10-2021-13@7 (04/11/2022)
10-2021-20@7 (04/18/2022)
10-2021-20@9 (04/18/2021)
10-2021-26@9 (04/24/2022)
NDC:
05446-0970-03

Quantity: 2204 vials

Product: CSF Otic Insufflation Capsule, 50mg / 30mg / 5mg, 5 count bottle
Variants: Otic Powder, For Otic Use with Insufflator
Lot Numbers:
10-2021-27@8 (01-25-2022)
NDC:
05446-1633-05

Quantity: 1055 bottles

Product: CSF-HC Otic Insufflation Capsule, 50mg/ 30mg/ 25mg/ 5mg, 5 count bottle
Variants: Otic Powder
Lot Numbers:
10-2021-05@9 (01/01/2022)
10-2021-28@4 (01/26/2022)
NDC:
05446-1634-01

Quantity: 440 cartons

Product: Dexamethasone sodium phosphate 0.4%, 120 mL bottle
Variants: Multiple Dose Container, Topical Use
Lot Numbers:
06-2021-23@6 (12/20/2021)
09-2021-15@4 (03/14/2022)
10-2021-04@10 (04/02/2022)
NDC:
05446-0622-01

Quantity: 56 cartons

Product: Dibutyl Squaric Acid, Topical Solution (PF), 2%, 10 mL vial
Variants: Multiple Dose Vial
Lot Numbers:
09-2021-15@5 (12/14/2021)
10-2021-01@4 (12/30/2021)
NDC:
05446-1047-03

Quantity: 63 vials

Product: Dibutyl Squaric Acid, Topical Solution (PF), 1%, 10 mL vial
Variants: Multiple Dose Vial
Lot Numbers:
08-2021-03@8 (12/31/2021)
09-2021-07@10 (02/04/2022)
NDC:
05446-1156-03

Quantity: 20 vials

Product: LT Topical Cream, Lidocaine/Tetracaine, 23%/7%, 60gm jar
Variants: Multiple Dose Container, Topical Use
Lot Numbers:
08-2021-23@9 (02/19/2022)
09-2021-07@13 (03/06/2022)
10-2021-22@5 (04/20/2022)
NDC:
05446-1647-01

Quantity: 74 jars

Product: LET Topical Gel, Lidocaine HCL / Epinepherine / Tetracaine HCl, 4%/0.05%/0.5%, 3 mL syringe
Variants: Single Dose Syringe, Topical Use
Lot Numbers:
07-2021-12@6 (12/09/2021)
07-2021-19@7 (12/16/2021)
07-2021-26@5 (12/23/2021)
08-2021-02@8 (12/30/2021)
08-2021-09@10 (01/06/2022)
08-2021-13@6 (01/10/2022)
08-2021-18@4 (01/15/2022)
08-2021-24@8 (01/21/2022)
08-2021-30@5 (01/27/2022)
09-2021-07@11 (02/04/2022)
09-2021-13@5 (02/10/2022)
10-2021-04@9 (03/03/2022)
NDC:
05446-0607-01

Quantity: 26917 syringes

Product: Lidocaine HCl / Oxymetazoline HCl Nasal Solution, 4% / 0.05%, 240mL bottle
Variants: Multiple Dose Container, Intranasal Use
Lot Numbers:
06-2021-18@3 (12/15/2021)
06-2021-30@10 (12/27/2021)
07-2021-14@4 (01/10/2022)
07-2021-21@4 (01/17/2022)
07-2021-28@9 (01/24/2022)
08-2021-12@8 (02/08/2022)
08-2021-24@9 (02/20/2022)
09-2021-09@10 (03/08/2022)
10-2021-05@6 (04/03/2022)
NDC:
05446-1256-01

Quantity: 386 bottles

Product: Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, Raspberry Marshmallow, 30g jar
Variants: Multiple Dose Container, Topical Oral Use
Lot Numbers:
07-2021-20@7 (01/16/2022)
08-2021-11@6 (02/07/2022)
08-2021-31@11 (02/01/2022)
09-2021-14@11 (02/01/2022)
09-2021-21@6 (02/01/2022)
10-2021-12@4 (04/10/2022)
NDC:
05446-0790-10

Quantity: 353 jars

Product: Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, Spearmint-Peppermint, 30g jar
Variants: Multiple Dose Container, Topical Oral Use
Lot Numbers:
08-2021-16@12 (02/01/2022)
09-2021-13@8 (02/01/2022)
09-2021-29@8 (03/01/2022)
10-2021-26@7 (04/24/2022)
NDC:
05446-0407-10

Quantity: 221 jars

Product: Profound-PE Dental Gel, Lidocaine HCl/ Prilocaine HCl/ Tetracaine HCl/ Phenylephrin HCl, Raspberry-Marshmallow, jar
Variants: Multiple Dose Container, Topical Oral Use
Lot Numbers:
06-2021-29@15 (12/26/2021)
07-2021-12@7 (01/08/2022)
08-2021-03@7 (01/30/2022)
08-2021-25@5 (02/01/2022)
09-2021-10@4 (02/01/2022)
09-2021-22@6 (03/01/2022)
10-2021-06@11 (04/04/2022)
NDC:
05446-1018-10

Quantity: 418 jars

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 89172
Status: Resolved
Manufacturer: Edge Pharma, LLC
Sold By: hospitals; clinics; physician offices
Manufactured In: United States
Units Affected: 54 products (30 bags; 4465 syringes; 8140 syringes; 168 syringes; 1720 syringes; 323 syringes; 80 droppers; 2568 syringes; 627 syringes; 1202 syringes; 1007 syringes; 457 syringes; 860 syringes; 163 syringes; 154 syringes; 860 syringes; 160 syringes; 199 syringes; 309 vials; 2463 vials; 3747 syringes; 6535 vials; 5335 syringes; 3930 bags; 2750 syringes; 363 droptainers; 2562 syringes; 40 droptainers; 1773 syringes; 3360 syringes; 1795 bags; 1825 bags; 749 bags; 1173 jars; 1173 vials; 2204 vials; 1055 bottles; 440 cartons; 56 cartons; 63 vials; 20 vials; 74 jars; 26917 syringes; 386 bottles; 353 jars; 221 jars; 418 jars; 175 jars; 1861 jars; 231 bottles; 757 syringes; 7788 syringes; 114 bottles; 6925 syringes)
Distributed To: Nationwide
Agency Last Updated: January 31, 2022

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.